Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinayak Viplav

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annals of African Medicine|June 19, 2026
A Clinico-epidemiological Profile of Facial Dermatoses at a Teaching Hospital in Eastern IndiaShivani, Vinayak Viplav
Italian Journal of Dermatology and Venereology|May 8, 2025
Omalizumab: a broader role in dermatology? Evidence and the road aheadAditya K Bubna, Vinayak Viplav
Italian Journal of Dermatology and Venereology|October 18, 2024
Revisiting risankizumab: a newer biologic drug in dermatologyAditya K Bubna, Vinayak Viplav
Dermatology Practical & Conceptual|August 9, 2024
Guselkumab - In Psoriasis and BeyondAditya Kumar Bubna, Vinayak Viplav
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annals of African Medicine|June 19, 2026
A Clinico-epidemiological Profile of Facial Dermatoses at a Teaching Hospital in Eastern IndiaShivani, Vinayak Viplav
Italian Journal of Dermatology and Venereology|May 8, 2025
Omalizumab: a broader role in dermatology? Evidence and the road aheadAditya K Bubna, Vinayak Viplav
Italian Journal of Dermatology and Venereology|October 18, 2024
Revisiting risankizumab: a newer biologic drug in dermatologyAditya K Bubna, Vinayak Viplav
Dermatology Practical & Conceptual|August 9, 2024
Guselkumab - In Psoriasis and BeyondAditya Kumar Bubna, Vinayak Viplav
Pageof 1